InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Steele Glenn Jr Md Phd. Director active across 1 company, notably PTC Therapeutics, INC.. In total, 5 reports have been logged. Activity tracked since 7 January 2022. The latest transaction was filed on 2 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Steele Glenn Jr Md Phd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
12,000 股@ US$30.86100.0% 占其流量Common StockSEC:0001269131-26-000003:0
4,000 股0Common StockSEC:0001415889-25-001028:0
4,000 股0Common StockSEC:0001415889-24-004099:0
4,000 股0Common StockSEC:0001415889-23-000670:0
3,200 股0Common StockSEC:0001179110-22-000383:0
5 条申报中的 5 条
About Steele Glenn Jr Md Phd
STEELE GLENN JR MD PHD is a declarant and, according to the provided records, a Director of PTC Therapeutics, INC. The total number of filings is 5, and the recent filings observed run from 2022-01-11 to 2025-01-07, with buy and sell amounts shown as EUR 0 in the sampled filings, and the modal transaction nature being Attribution.
